Let's prevent diabetes: Study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Gray, Laura J ^a   Khunti, Kamlesh ^a   Williams, Sian ^b   Goldby, Stephanie ^b   Troughton, Jacqui ^b   Yates, Thomas ^a   Gray, Alastair ^c   Davies, Melanie J ^a,d   Farooqi, A ^e   Carey, M ^e   Abrams, K ^e   Skinner, T ^e   Tuomilehto, J ^e   Heller, S ^e   Samani, N ^e   Stribling, B ^e   Jones, B ^e  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e NONE

Author keywords

Cluster randomised controlled trial; Impaired glucose regulation; Prevention; Screening; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES EDUCATION; FOLLOW UP; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CLUSTER ANALYSIS; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; GREAT BRITAIN; HEALTH BEHAVIOR; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MASS SCREENING; MOTIVATION; PATIENT EDUCATION AS TOPIC; PREVENTIVE HEALTH SERVICES; PRIMARY HEALTH CARE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; TELEPHONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861130300     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-56     Document Type: Article

References (58)

1. Kuznik A, Mardekian J. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Cardiovasc Diabetol 2011, 10:31. 10.1186/1475-2840-10-31, 3098774, 21496321.
2. World Health Organization global health risks: mortality and burden of disease attributable to selected major risk factors 2009, World Health Organization, Geneva, World Health Organization.
3. Zhang P, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301. 10.1016/j.diabres.2010.01.026, 20171754.
4. Khunti K, et al. Unanswered questions over NHS health checks. BMJ 2011, 342:316-318.
5. Gillies CL, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007, 334:299. 10.1136/bmj.39063.689375.55, 1796695, 17237299.
6. Lauritzen T, Borch-Johnsen K, Sandbaek A. Is prevention of type 2 diabetes feasible and efficient in primary care? A systematic PubMed review. Prim Care Diabetes 2007, 1:5-11. 10.1016/j.pcd.2006.11.001, 18632013.
7. Yates T, Khunti K, Davies MJ. Prevention of diabetes: a reality in primary care?. Prim Care Diabetes 2007, 1:119-121. 10.1016/j.pcd.2007.07.003, 18632031.
8. Absetz P, et al. Type 2 diabetes prevention in the "real world: three-year results of the GOAL Implementation Trial. Diabetes Care 2009, 32:1418-1420. 10.2337/dc09-0039, 2713644, 19401442.
9. Ackermann RT, et al. Translating the diabetes prevention program into the community: the deploy pilot study. Am J Prev Med 2008, 35:357-63. 10.1016/j.amepre.2008.06.035, 2610485, 18779029.
10. Laatikainen T, et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health 2007, 7:249. 10.1186/1471-2458-7-249, 2039742, 17877832.
11. Schwarz PE, et al. Development of a diabetes prevention management program for clinical practice. Public Health Rep 200, 122:258-263.
12. Yates T, et al. Effectiveness of a pragmatic education programme aimed at promoting walking activity in individuals with impaired glucose tolerance: a randomized controlled trial. Diabetes Care 2009, 32:1404-10. 10.2337/dc09-0130, 2713638, 19602539.
13. Yates T, et al. The Prediabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at two years?. Diabet Med 2011, 10:1268-1271.
14. Excellence., N.I.f.H.a.C Type 2 diabetes: National clinical guideline for management in primary and secondary care (update) 2008, Royal Collage of Physicians, London, Excellence., N.I.f.H.a.C.
15. UK., D.o.H.D Structured patient education in diabetes: Report from the Patient Education Working Group 2005, Department of Health, London, UK., D.o.H.D.
16. Gillett M, et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ 2010, 341:c4093. 10.1136/bmj.c4093, 2924963, 20729270.
17. Waugh N, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007, 11(17):1-125.
18. Eborall H, et al. Influences on the uptake of diabetes screening: a qualitative study in primary care. Br J Gen Pract 2012, 62(596):e204-11. 10.3399/bjgp12X630106, 22429438.
19. Webb DR, et al. Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 2011, 54(9):2237-46. 10.1007/s00125-011-2189-2, 21638133.
20. Goyder E, et al. National evaluation of DHDS Diabetes Screening Pilot Programme. Final Report 2008, School of Health and Related Research, University of Sheffield.
21. Sargeant LA, et al. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. Diabet Med 2010, 27(9):995-1003. 10.1111/j.1464-5491.2010.03056.x, 3428846, 20722672.
22. Schwarz P, et al. Non-pharmacological intervention for diabetes mellitus prevention in populations: Where do we stand. Nat Rev Endocrinol 2012,
23. Collins GS, et al. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011, 9:103. 10.1186/1741-7015-9-103, 3180398, 21902820.
24. Gray LJ, et al. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 2012, 55(4):959-996. 10.1007/s00125-011-2432-x, 22231125.
25. World Health Organisation Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus 1999, World Health Organisation, Geneva, World Health Organisation.
26. Office of the Deputy Prime Minister The English Indices of Deprivation 2007 (Revised) 2007, ODPM Publications, London, webcite and 2007, Office of the Deputy Prime Minister., http://www.communities.gov.uk/communities/neighbourhoodrenewal/deprivation/deprivation07/
27. Roe L, et al. Dietary intervention in primary care: Validity of the DINE method for diet assessment. Fam Pract 1994, 11:375-381. 10.1093/fampra/11.4.375, 7895964.
28. Sintonen H, Pekurinen M, et al. A fifteen-dimensional measure of health-related quality of life (15D) and its applications. Kirjassa. Quality of Life Assessment: Key Issues in the 1990s 1992, 185-195. Kluver Academic Publishers, Dordrecht, Walker SR.
29. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 2006, 67:361-70.
30. Broadbent E, et al. The brief illness perception questionnaire. J Psychosom Res 2006, 60:631-637. 10.1016/j.jpsychores.2005.10.020, 16731240.
31. Craig CL, et al. International physical activity questionnaire: 12-country reliability and validity. Medicine and science in sports and exercise 2003, 35:1381-1395. 10.1249/01.MSS.0000078924.61453.FB, 12900694.
32. Kita T, et al. Short sleep duration and poor sleep quality increase the risk of diabetes in Japanese workers with no family history of diabetes. Diabetes Care 2012, 35(2):313-8. 10.2337/dc11-1455, 22210572.
33. Craig P, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337:a1655. 10.1136/bmj.a1655, 2769032, 18824488.
34. Frei A, et al. The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. Cardiovascular Diabetology 2010, 9.
35. Shah BR, et al. Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: protocol for a cluster-randomized pragmatic trial. Trials 2010, 11:44. 10.1186/1745-6215-11-44, 2867980, 20416080.
36. Jansink R, et al. Nurse-led motivational interviewing to change the lifestyle of patients with type 2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle recommendations. BMC Health Serv Res 2009, 9:19. 10.1186/1472-6963-9-19, 2646713, 19183462.
37. Webb D, et al. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 2010, 19(11):16.
38. Kind P, et al. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998, 316:736-741. 10.1136/bmj.316.7133.736, 28477, 9529408.
39. Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. Medical psychology (Vol II, pp.7-30) 1980, Pergamon Press, New York, Rachman S.
40. Chaiken S. The Heuristic model of persuasion, in Social influence. The Ontario symposium 1987, 3-39. Erlbaum, Hillsdale, Zanna MP, Olson JM, Herman CP.
41. Bandura A. Self-efficacy: The exercise of control 1997, W.H. Freeman, New York.
42. Gollwitzer PM. Implementation intentions: strong effects of simple plans:How can good intentions become effective behaviour change strategies?. American Psychologist 1999, 54:493-503.
43. Funnell MM, et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educator 1992, 17:37-41.
44. Diabetes Prevention Programme Research Group Reduction in the incidence of type 2 diabetes with lifestyle intrevention and metformin. New ENgland Journal of Medicine 2002, 346:393-403. 1370926, 11832527, Diabetes Prevention Programme Research Group.
45. Tuomilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England journal of medicine 2001, 344(18):1343-1350. 10.1056/NEJM200105033441801, 11333990.
46. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, Dallosso HM, Daly H, Doherty Y, Eaton S, Fox C, Oliver L, Rantell K, Rayman G, Khunti K, . on behalf of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. British Medical Journal 2008, 336:491-495. 10.1136/bmj.39474.922025.BE, 2258400, 18276664, on behalf of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative.
47. Stone M, et al. Using qualitative research methods to inform the development of a modified version of a patient education module for non English speakers with type 2 diabetes: experiences from an action research project on two south asian populations in the UK. Diversity in health and Social Care 2008, 3:199-206.
48. D'Agostino RB, et al. Validation of the framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286(2):180-7. 10.1001/jama.286.2.180, 11448281.
49. Expert Panel On Detection E., And Treatment Of High Blood Cholesterol In Adults,, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-97. 10.1001/jama.285.19.2486, 11368702, Expert Panel On Detection.
50. Ramachandran A, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49(2):289-297. 10.1007/s00125-005-0097-z, 16391903.
51. Lindström J, et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26(12):3230-6. 10.2337/diacare.26.12.3230, 14633807.
52. Yamaoka K, Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2005, 28:2780-2786. 10.2337/diacare.28.11.2780, 16249558.
53. Yates T, et al. The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 2007, 50:1116-1126. 10.1007/s00125-007-0638-8, 1871609, 17415549.
54. Campbell MK, Elbourne DR ADG. CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328(7441):702-708. 10.1136/bmj.328.7441.702, 381234, 15031246.
55. Paulweber B, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010, 42(Suppl. 1):42.
56. Programme TD. , http://www.desmond-project.org.uk/. 24/04/2012
57. Walker N, et al. The vascular risk assessment programme: implications for the delivery in primary care. Diabetes and Primary Care 2009, 11:4.
58. National Institute for Health and Clinical Excellence Public Health Draft Guidence, Preventing type 2 diabetes: risk identification and interventions for individuals at high risk 2011, National Institute for Health and Clinical Excellence, London, National Institute for Health and Clinical Excellence.